A two-week, double-blind, placebo-controlled trial of Viola odorata, Echium amoenum and Physalis alkekengi mixture in symptomatic benign prostate hyperplasia (BPH) men

References

• Aaron L, Franco OE, Hayward SW. 2016. Review of prostate anatomy and embryology and the etiology of benign prostatic hyperplasia. Urol Clin N Am. 43:279–288.
   PubMed Web of Science ®Google Scholar
• Abolhassani M. 2004. Antibacterial effect of borage (Echium amoenum) on Staphylococcus aureus. Braz J Infect Dis. 8:382–385.
   PubMedGoogle Scholar
• Alivizatos G, Skolarikos A. 2008. Obstructive uropathy and benign prostatic hyperplasia. The aging kidney in health and disease. USA: Springer.
   Google Scholar
• Andriole G, Bruchovsky N, Chung LW, Matsumoto AM, Rittmaster R, Roehrborn C, Russell D, Tindall D. 2004. Dihydrotestosterone and the prostate: the scientific rationale for 5α-reductase inhibitors in the treatment of benign prostatic hyperplasia. J Urol. 172:1399–1403.
   PubMed Web of Science ®Google Scholar
• Ballabh B, Chaurasia O, Ahmed Z, Singh SB. 2008. Traditional medicinal plants of cold desert Ladakh-used against kidney and urinary disorders. J Ethnopharmacol. 118:331–339.
   PubMed Web of Science ®Google Scholar
• Berges R, Windeler J, Trampisch H, Senge T. Group β-SS. 1995. Randomised, placebo-controlled, double-blind clinical trial of β-sitosterol in patients with benign prostatic hyperplasia. Lancet. 345:1529–1532.
   PubMed Web of Science ®Google Scholar
• Bostanci Y, Kazzazi A, Momtahen S, Laze J, Djavan B. 2013. Correlation between benign prostatic hyperplasia and inflammation. Curr Opin Urol. 23:5–10.
   PubMed Web of Science ®Google Scholar
• Breyer BN, Kenfield SA, Blaschko SD, Erickson BA. 2014. The association of lower urinary tract symptoms, depression and suicidal ideation: data from the 2005–2006 and 2007–2008 National Health and Nutrition Examination Survey. J Urol. 191:1333–1339.
   PubMed Web of Science ®Google Scholar
• Bullock TL, Andriole GL. Jr. 2006. Emerging drug therapies for benign prostatic hyperplasia. Expert Opin Emerg Drugs. 11:111–123.
   PubMedGoogle Scholar
• Chinese Pharmacopoeia Committee. 2005. Pharmacopoeia of the People’s Republic of China. Vol. 1. Beijing, China: Chemical Industry Press; p. 250–251.
   Google Scholar
• Chughtai B, Lee R, Te A, Kaplan S. 2011. Role of inflammation in benign prostatic hyperplasia. Rev Urol. 13:147–150.
   PubMedGoogle Scholar
• Clark RV, Hermann DJ, Cunningham GR, Wilson TH, Morrill BB, Hobbs S. 2004. Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5alpha-reductase inhibitor. J Clin Endocrinol Metab. 89:2179–2184.
   PubMed Web of Science ®Google Scholar
• Debruyne FM. 2000. Alpha blockers: are all created equal? Urology. 56:20–22.
   PubMed Web of Science ®Google Scholar
• Drozdova I, Bubenchikov R. 2005. Composition and antiinflammatory activity of polysaccharide complexes extracted from sweet violet and low mallow. Pharm Chem. 39:197–200.
   Google Scholar
• Dweck AC. 2006. Isoflavones, phytohormones and phytosterols. J Appl Cosmetol. 24:17.
   Google Scholar
• Engel W. 1964. Uropsychiatry. J Mich State Med Soc. 63:273.
   PubMedGoogle Scholar
• Gharib Naseri MK, Mohammadian M, Gharib Naseri Pharm Z. 2008. Antispasmodic effect of Physalis alkekengi fruit extract. Int J Reprod Biomed. 6:193–198.
   Google Scholar
• Gormley GJ, Stoner E, Bruskewitz RC, Imperato-McGinley J, Walsh PC, McConnell JD, Andriole GL, Geller J, Bracken BR, Tenover JS. 1992. The effect of finasteride in men with benign prostatic hyperplasia. N Engl J Med. 327:1185–1191.
   PubMed Web of Science ®Google Scholar
• Huri HZ, Xin CH, Sulaiman CZ. 2014. Drug-related problems in patients with benign prostatic hyperplasia: a cross sectional retrospective study. PLoS One. 9:e86215.
   PubMed Web of Science ®Google Scholar
• Johnson TV, Abbasi A, Ehrlich SS, Kleris RS, Raison CL, Master VA. 2011. Nocturia associated with depressive symptoms. Urology. 77:183–186.
   PubMed Web of Science ®Google Scholar
• Keehn A, Lowe FC. 2015. Complementary and alternative medications for benign prostatic hyperplasia. Can J Urol. 22:18–23.
   PubMedGoogle Scholar
• Keehn A, Taylor J, Lowe FC. 2016. Phytotherapy for benign prostatic hyperplasia. Curr Urol Rep. 17:1–6.
   PubMed Web of Science ®Google Scholar
• Kim EH, Larson JA, Andriole GL. 2016. Management of benign prostatic hyperplasia. Annu Rev Med. 67:137–151.
   PubMed Web of Science ®Google Scholar
• Klippel K, Hiltl D, Schipp B. 1997. A multicentric, placebo-controlled, double-blind clinical trial of beta-sitosterol (phytosterol) for the treatment of benign prostatic hyperplasia. German BPH-Phyto Study group. Br J Urol. 80:427–432.
   PubMedGoogle Scholar
• Lim T. 2014. Viola odorata. In: Lim TK, editor. Edible medicinal and non medicinal plants. New York: Springer; p. 795–807.
   Google Scholar
• MacDonald R, Tacklind JW, Rutks I, Wilt TJ. 2012. Serenoa repens monotherapy for benign prostatic hyperplasia (BPH): an updated Cochrane systematic review. BJU Int. 109:1756–1761.
   PubMed Web of Science ®Google Scholar
• Miller J, Tarter T. 2009. Combination therapy with dutasteride and tamsulosin for the treatment of symptomatic enlarged prostate. Clin Interv Aging. 4:251–258.
   PubMed Web of Science ®Google Scholar
• Mittal S. 2013. Thin layer chromatography and high pressure liquid chromatography profiling of plant extracts of Viola odorata L. Int J Pharma Bio Sci. 4:B542–B549.
   Google Scholar
• Molinuevo B, Batista‐Miranda JE. 2012. Under the tip of the iceberg: psychological factors in incontinence. Neurourol Urodyn. 31:669–671.
   PubMed Web of Science ®Google Scholar
• Narayan P, Tunuguntla HSGR. 2005. Long-term efficacy and safety of tamsulosin for benign prostatic hyperplasia. Rev Urol. 7:S42.
   PubMedGoogle Scholar
• Naser S, Jasem E, Maryam SL, Hassan HS. 2008. Effects of alcoholic extract of Physalis alkekengi on the reproductive system, spermatogenesis and sex hormones of adult NMRI mice. Pharmacol Online. 3:110–118.
   Google Scholar
• Nicholson TM, Ricke WA. 2011. Androgens and estrogens in benign prostatic hyperplasia: past, present and future. Differentiation. 82:184–199.
   PubMed Web of Science ®Google Scholar
• Nickel JC. 2008. Inflammation and benign prostatic hyperplasia. Urol Clin N Am. 35:109–115.
   PubMed Web of Science ®Google Scholar
• Qiu L, Zhao F, Liu H, Chen L, Jiang Z, Liu H, Wang N, Yao X, Qiu F. 2008. Two new megastigmane glycosides, physanosides A and B, from Physalis alkekengi L. var. franchetii, and their effect on NO release in macrophages. Chem Biodiver. 5:758–763.
   PubMed Web of Science ®Google Scholar
• Sayyah M, Boostani H, Pakseresht S, Malaieri A. 2009. Efficacy of aqueous extract of Echium amoenum in treatment of obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 33:1513–1516.
   PubMed Web of Science ®Google Scholar
• Sayyah M, Sayyah M, Kamalinejad M. 2006. A preliminary randomized double blind clinical trial on the efficacy of aqueous extract of Echium amoenum in the treatment of mild to moderate major depression. Prog Neuropsychopharmacol Biol Psychiatry. 30:166–169.
   PubMed Web of Science ®Google Scholar
• Schalken JA. 2015. Inflammation in the pathophysiology of benign prostatic hypertrophy. Eur Urol Suppl. 14:e1455–e1458.
   Web of Science ®Google Scholar
• Shafaghi B, Naderi N, Tahmasb L, Kamalinejad M. 2010. Anxiolytic effect of Echium amoenum L. in mice. Iran J Pharm Res. 37–41.
   PubMed Web of Science ®Google Scholar
• Shrivastava A, Gupta VB. 2012. Various treatment options for benign prostatic hyperplasia: a current update. J Midlife Health. 3:10.
   PubMedGoogle Scholar
• Tarter T, Vaughan J. 2006. Inhibitors of 5alpha-reductase in the treatment of benign prostatic hyperplasia. Curr Pharm Des. 12:775–783.
   PubMed Web of Science ®Google Scholar
• Tewari AK, Whelan P, Graham JD. 2013. Prostate cancer: diagnosis and clinical management. New York: John Wiley & Sons.
   Google Scholar
• Untergasser G, Madersbacher S, Berger P. 2005. Benign prostatic hyperplasia: age-related tissue-remodeling. Exp Gerontol. 40:121–128.
   PubMed Web of Science ®Google Scholar
• Vishal A, Parveen K, Pooja S, Kannappan N, Kumar S. 2009. Diuretic, laxative and toxicity studies of Viola odorata aerial parts. Pharmacol Online. 1:739–748.
   Google Scholar
• Wong SY, Woo J, Leung JC, Leung PC. 2010. Depressive symptoms and lifestyle factors as risk factors of lower urinary tract symptoms in Southern Chinese men: a prospective study. Aging Male. 13:113–119.
   PubMed Web of Science ®Google Scholar
• Zegarra L, Vaisberg A, Loza C, Aguirre RL, Campos M, Fernandez I, Talla O, Villegas L. 2007. Double-blind randomized placebo-controlled study of Bixa orellana in patients with lower urinary tract symptoms associated to benign prostatic hyperplasia. Int Braz J Urol. 33:493–501.
   PubMedGoogle Scholar